Protein-DNA Interactions Regulate Human Papillomavirus DNA Replication, Transcription, and Oncogenesis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 May 2023
Historique:
received: 27 03 2023
revised: 30 04 2023
accepted: 02 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Human papillomavirus (HPV) is a group of alpha papillomaviruses that cause various illnesses, including cancer. There are more than 160 types of HPV, with many being "high-risk" types that have been clinically linked to cervical and other types of cancer. "Low-risk" types of HPV cause less severe conditions, such as genital warts. Over the past few decades, numerous studies have shed light on how HPV induces carcinogenesis. The HPV genome is a circular double-stranded DNA molecule that is approximately 8 kilobases in size. Replication of this genome is strictly regulated and requires two virus-encoded proteins, E1 and E2. E1 is a DNA helicase that is necessary for replisome assembly and replication of the HPV genome. On the other hand, E2 is responsible for initiating DNA replication and regulating the transcription of HPV-encoded genes, most importantly the E6 and E7 oncogenes. This article explores the genetic characteristics of high-risk HPV types, the roles of HPV-encoded proteins in HPV DNA replication, the regulation of transcription of E6 and E7 oncogenes, and the development of oncogenesis.

Identifiants

pubmed: 37239839
pii: ijms24108493
doi: 10.3390/ijms24108493
pmc: PMC10218588
pii:
doi:

Substances chimiques

Oncogene Proteins, Viral 0
Papillomavirus E7 Proteins 0
DNA 9007-49-2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Virol. 2002 Dec;76(24):13039-48
pubmed: 12438630
Open Virol J. 2012;6:173-89
pubmed: 23341853
Mol Cell. 2006 Dec 28;24(6):867-76
pubmed: 17189189
Clin Microbiol Rev. 2003 Jan;16(1):1-17
pubmed: 12525422
Cell. 2004 Apr 30;117(3):349-60
pubmed: 15109495
Nature. 1970 Dec 19;228(5277):1184-6
pubmed: 4321099
J Virol. 2001 Feb;75(3):1565-70
pubmed: 11152531
Virology. 2003 Sep 15;314(1):161-7
pubmed: 14517069
PLoS One. 2008 Oct 02;3(10):e3313
pubmed: 18836553
Int J Cancer. 2017 Nov 15;141(10):1997-2001
pubmed: 28734013
Oncogene. 1998 Dec 10;17(23):2943-54
pubmed: 9881696
Clin Sci (Lond). 2017 Aug 10;131(17):2201-2221
pubmed: 28798073
J Virol. 2008 Nov;82(21):10841-53
pubmed: 18753207
J Virol. 2000 Apr;74(8):3752-60
pubmed: 10729150
J Virol. 1993 Nov;67(11):6424-31
pubmed: 8411344
J Biol Chem. 1994 Sep 30;269(39):24058-65
pubmed: 7523366
Oncogene. 2011 Dec 15;30(50):4963-76
pubmed: 21625213
EMBO J. 1988 Feb;7(2):525-31
pubmed: 2835231
J Virol. 1994 Feb;68(2):1115-27
pubmed: 8289341
Cell. 1993 Nov 5;75(3):495-505
pubmed: 8221889
Rev Obstet Gynecol. 2008 Winter;1(1):2-10
pubmed: 18701931
Cancer Res Treat. 2005 Dec;37(6):319-24
pubmed: 19956366
J Virol. 1995 Oct;69(10):6323-34
pubmed: 7666533
Clinics (Sao Paulo). 2018 Oct 11;73(suppl 1):e486s
pubmed: 30328948
J Virol. 1996 Mar;70(3):1602-11
pubmed: 8627680
Ciba Found Symp. 1972;7:245-59
pubmed: 4580344
Nucleic Acids Res. 1992 Jan 25;20(2):251-6
pubmed: 1311070
J Biol Chem. 1997 Mar 28;272(13):8236-42
pubmed: 9079642
PLoS Pathog. 2012;8(4):e1002657
pubmed: 22536154
J Gen Virol. 2010 Feb;91(Pt 2):521-30
pubmed: 19812262
Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:13-22
pubmed: 28528686
Viruses. 2015 Jul 16;7(7):3863-90
pubmed: 26193301
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):918-924
pubmed: 30138307
J Virol. 2005 Mar;79(6):3737-47
pubmed: 15731267
J Virol. 2007 Apr;81(8):4338-42
pubmed: 17287259
Virology. 2013 Oct;445(1-2):99-114
pubmed: 23731971
J Virol. 1993 Aug;67(8):4521-32
pubmed: 8392596
Infect Genet Evol. 2018 Jul;61:134-144
pubmed: 29518579
J Virol. 2012 Jan;86(1):348-57
pubmed: 22031941
Virus Res. 2017 Mar 2;231:76-82
pubmed: 27965149
Front Microbiol. 2012 Apr 24;3:152
pubmed: 22536200
J Virol. 2009 Mar;83(6):2592-600
pubmed: 19129460
J Mol Biol. 2008 Jan 25;375(4):1165-77
pubmed: 18067922
J Gen Virol. 1999 Jun;80 ( Pt 6):1513-1517
pubmed: 10374970
Virology. 2013 Oct;445(1-2):57-79
pubmed: 23849793
Genes Dev. 1997 Aug 15;11(16):2090-100
pubmed: 9284048
Nat Commun. 2022 May 10;13(1):2563
pubmed: 35538075
J Virol. 2016 Sep 12;90(19):8384-8
pubmed: 27412596
Cancer Res. 1996 Oct 15;56(20):4620-4
pubmed: 8840974
J Virol. 1990 Jun;64(6):2849-59
pubmed: 2159546
Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5799-803
pubmed: 1321423
Mol Oncol. 2022 Aug;16(16):3001-3016
pubmed: 35398964
Nature. 2000 Feb 17;403(6771):805-9
pubmed: 10693813
Bibl Haematol. 1975 Oct;(43):569-71
pubmed: 183728
Oncogene. 1996 Dec 5;13(11):2323-30
pubmed: 8957073
JAMA Oncol. 2016 May 01;2(5):599-606
pubmed: 26794505
PLoS Pathog. 2017 Apr 6;13(4):e1006211
pubmed: 28384274
J Obstet Gynaecol. 2020 Jul;40(5):602-608
pubmed: 31500479
Virology. 2015 Feb;476:341-344
pubmed: 25577151
Open Virol J. 2011;5:80-95
pubmed: 21769307
Br J Dermatol. 2015 Jan;172(1):196-201
pubmed: 24976535
J Virol. 2004 Nov;78(22):12179-88
pubmed: 15507604
Cell. 1990 Dec 21;63(6):1129-36
pubmed: 2175676
J Virol. 1997 May;71(5):3853-63
pubmed: 9094661
Adv Virus Res. 2008;72:155-205
pubmed: 19081491
Biochim Biophys Acta Gen Subj. 2018 Apr;1862(4):979-990
pubmed: 29288769
Future Microbiol. 2010 Oct;5(10):1493-506
pubmed: 21073310
Br J Cancer. 2021 Feb;124(4):777-785
pubmed: 33191407
J Biol Chem. 1987 Jul 25;262(21):10327-34
pubmed: 3038874
Oncogene. 1992 Jan;7(1):27-32
pubmed: 1311063
Cell Cycle. 2006 Jul;5(14):1499-502
pubmed: 16861919
Virology. 2013 Oct;445(1-2):175-86
pubmed: 23689062
J Virol. 1996 Nov;70(11):7549-60
pubmed: 8892874
J Virol. 1992 Oct;66(10):5949-58
pubmed: 1326651
Genes Dev. 1997 Aug 15;11(16):2101-11
pubmed: 9284049
J Virol. 2002 Oct;76(19):10009-14
pubmed: 12208977
Virol J. 2010 Jan 06;7:2
pubmed: 20051141
Cell. 1988 Sep 23;54(7):915-8
pubmed: 2843291
Virol J. 2019 Mar 4;16(1):27
pubmed: 30832688
Virology. 1990 Feb;174(2):557-75
pubmed: 2154890
Future Virol. 2011 Jan 1;6(1):45-57
pubmed: 21318095
Annu Rev Biophys Biomol Struct. 2002;31:343-60
pubmed: 11988474
Virology. 2014 Nov;468-470:311-321
pubmed: 25222147
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):17952-7
pubmed: 15598736
Int J Mol Sci. 2023 Mar 31;24(7):
pubmed: 37047526
J Biol Chem. 2002 Jun 14;277(24):21730-9
pubmed: 11934887
NPJ Genom Med. 2016 Mar 16;1:16004
pubmed: 29263809
J Biol Chem. 1989 Jun 25;264(18):10699-708
pubmed: 2525129
J Virol. 1989 Oct;63(10):4317-24
pubmed: 2476572
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3752-7
pubmed: 20133580
J Biol Chem. 2004 Jun 11;279(24):25729-44
pubmed: 15073179
J Virol. 2008 Oct;82(19):9600-14
pubmed: 18632871

Auteurs

Roxanne Evande (R)

Department of Medical and Molecular Sciences, University of Delaware, Newark, DE 19716, USA.

Anshul Rana (A)

Department of Medical and Molecular Sciences, University of Delaware, Newark, DE 19716, USA.

Esther E Biswas-Fiss (EE)

Department of Medical and Molecular Sciences, University of Delaware, Newark, DE 19716, USA.

Subhasis B Biswas (SB)

Department of Medical and Molecular Sciences, University of Delaware, Newark, DE 19716, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH